Off-topic for aiqbench

This story was gathered from a source we follow but falls outside AI and quantum coverage, so there is no aiqbench take for it.

The scariest thing about gray-market peptides is how little we know

The VergeOctober 7, 20267 min read

The peptide wild west is hard to quantify. | Image: Cath Virginia / The Verge, Getty Images This is Optimizer, a weekly newsletter sent from Verge senior reviewer Victoria Song that dissects and discusses the latest gizmos and potions that swear they're going to change your life. Opt in for Optimizer here. Finding concrete data about gray-market peptides is a Sisyphean task. Unlike bona fide clinical drug trials, there are no official numbers. There's little to no safety data. Some peptides have more anecdotal evidence than others, but a stranger on r/peptides is, perhaps, not an ideal information source. The fact is most people partaking in a dubiously legal activity aren't going to shout it from the rooftops. What we do know abo … Read the full story at The Verge.

This is Optimizer, a weekly newsletter sent from Verge senior reviewer Victoria Song that dissects and discusses the latest gizmos and potions that swear they’re going to change your life. Opt in for Optimizer here. Finding concrete data about gray-market peptides is a Sisyphean task. Unlike bona fide clinical drug trials, there are no official numbers. There’s little to no safety data. Some peptides have more anecdotal evidence than others, but a stranger on r/peptides is, perhaps, not an ideal information source. The fact is most people partaking in a dubiously legal activity aren’t going to shout it from the rooftops. What we do know about many of these unregulated, unapproved substances is simply this: A lot of people are taking them, unsupervised by medical professionals. Take BPC-157 — one half of the infamous…

Excerpt shown under the publisher's RSS terms · 134 words · full text and figures are on the publisher's site

Read at The Verge ↗Ask about this article